India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress,...
from NDTV News - Latest https://ift.tt/3iU2Gg6
via IFTTT
from NDTV News - Latest https://ift.tt/3iU2Gg6
via IFTTT
Advertisement
